Coherus Oncology (CHRS) EBITDA (2013 - 2026)
Coherus Oncology (CHRS) posted EBITDA of -$31.47 million for Q2 2026, compared with -$44.47 million a year earlier.
Powered by 
Analysis
Coherus Oncology (CHRS) EBITDA (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Coherus Oncology was -$155.09 million; for FY2025, it was -$177.21 million.
- In prior years, Coherus Oncology's EBITDA was -$194.38 million in FY2024, -$199.41 million in FY2023, -$253.18 million in FY2022 and -$260.4 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly EBITDA since Q3 2023.
- According to Business Quant data, EBITDA for the three prior quarters was -$35.27 million (Q1 2026), -$44.98 million (Q4 2025) and -$43.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn | -31.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.47 Mn |
| Mar 31, 2026 | -35.27 Mn |
| Dec 31, 2025 | -44.98 Mn |
| Sep 30, 2025 | -43.37 Mn |
| Jun 30, 2025 | -44.47 Mn |
| Mar 31, 2025 | -44.39 Mn |
| Dec 31, 2024 | -44.35 Mn |
| Sep 30, 2024 | -45.31 Mn |
| Jun 30, 2024 | -38.44 Mn |
| Mar 31, 2024 | -66.28 Mn |
| Dec 31, 2023 | -67.25 Mn |
| Sep 30, 2023 | -30.52 Mn |
| Jun 30, 2023 | -33.09 Mn |
| Mar 31, 2023 | -66.14 Mn |
| Dec 31, 2022 | -49.64 Mn |
| Sep 30, 2022 | -78.60 Mn |
| Jun 30, 2022 | -42.13 Mn |
| Mar 31, 2022 | -76.46 Mn |
| Dec 31, 2021 | -37.60 Mn |
| Sep 30, 2021 | -30.80 Mn |
API Access
Coherus Oncology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();